ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Markowitz LE , Dunne EF , Saraiya M , Chesson HW , Curtis CR , Gee J , Bocchini JA Jr. , Unger ER , 2014. Human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 63: 1–30.
-
2.
Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S, 2023. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023. Available from: https://hpvcentre.net/statistics/reports/XWX.pdf. Accessed November 14, 2023.
-
3.
LaVigne AW , Triedman SA , Randall TC , Trimble EL , Viswanathan AN , 2017. Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery. Gynecol Oncol Rep 22: 16–20.
-
4.
Bruni L , Diaz M , Castellsagué M , Ferrer E , Bosch FX , de Sanjosé S , 2010. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202: 1789–1799.
-
5.
Ahmed S et al., 2023. Genotypic distribution of human papillomavirus and phylogenetic analysis of E6 and E7 gene of HR-HPV variants isolated from Pakistani population. Medicine (Baltimore) 102: e32651.
-
6.
Burchell AN , Winer RL , de Sanjosé S , Franco EL , 2006. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 24: S52–S61.
-
7.
Plummer M , Franceschi S , 2002. Strategies for HPV prevention. Virus Res 89: 285–293.
-
8.
Kitchener HC , Castle PE , Cox JT , 2006. Achievements and limitations of cervical cytology screening. Vaccine 24: S63–S70.
-
9.
Loya A , Serrano B , Rasheed F , Tous S , Hassan M , Clavero O , Raza M , De Sanjosé S , Bosch FX , Alemany L , 2016. Human papillomavirus genotype distribution in invasive cervical cancer in Pakistan. Cancers (Basel) 8: 72.
-
10.
Gele AA , Qureshi SA , Kour P , Kumar B , Diaz E , 2017. Barriers and facilitators to cervical cancer screening among Pakistani and Somali immigrant women in Oslo: A qualitative study. Int J Womens Health 6: 487–496.
-
11.
Ahmad M , Narayan E , Ahmed I , Bule MH , 2023. Inadequate cervical cancer testing facilities in Pakistan: A major public health concern. IJS Global Health 6: e0336.
-
12.
Riaz L , Manazir S , Jawed F , Ali SA , Riaz R , 2020. Knowledge, perception, and prevention practices related to human papillomavirus-based cervical cancer and its socioeconomic correlates among women in Karachi, Pakistan. Cureus 12: e7183.
-
13.
Portnoy A , Abbas K , Sweet S , Kim JJ , Jit M , 2021. Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: A comparative modelling study. BMJ Glob Health 6: e006940.
-
14.
Van Minh H , My NTT , Jit M , 2017. Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: A PRIME modeling study. BMC Health Serv Res 17: 1–7.
-
15.
Strategic Advisory Group of Experts (SAGE) on Immunization , 2022. Strategic Advisory Group of Experts (SAGE) Working Group on Potential Contribution of HPV Vaccines and Immunization towards Cervical Cancer Elimination: Background Document and Report to SAGE. Geneva, Switzerland: World Health Organization.
-
16.
World Health Organization , 2016. Guide to Introducing HPV Vaccine into National Immunization Programmes. Geneva, Switzerland: World Health Organization.
-
17.
Prem K et al., 2023. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: A comparative modelling analysis. BMC Med 21: 313.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1942 | 1359 | 241 |
| Full Text Views | 55 | 36 | 15 |
| PDF Downloads | 62 | 39 | 14 |
Contemplating the Human Papillomavirus (HPV) Vaccine Introduction in Pakistan: Is Now the Time?
Rabab Batool
Rabab Batool
Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan; Centre for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
Search for other papers by Rabab Batool in
Current site
Google Scholar
PubMed
Search for other papers by Rabab Batool in
Current site
Google Scholar
PubMed
ABSTRACT.
Human papillomavirus (HPV) vaccine introduction is anticipated in many countries in the coming years. This Perspective addresses the opportunities and challenges of introducing HPV vaccination in Pakistan. A substantial portion of the population within the high-risk age group necessitates the implementation of a robust vaccination strategy. Advocacy, community mobilization, and stakeholder engagement are the key elements for the successful implementation of the vaccination program. However, for long-term control strategies, a multifaceted approach is recommended. This approach should involve integrating HPV vaccination into the national immunization program, improving access to screening methods, and establishing comprehensive and cost-effective programs for preventing cervical cancer.
Author Notes
Author’s address: Rabab Batool, Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Sind, Pakistan, E-mail: rabab.batool@aku.edu.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Markowitz LE , Dunne EF , Saraiya M , Chesson HW , Curtis CR , Gee J , Bocchini JA Jr. , Unger ER , 2014. Human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 63: 1–30.
-
2.
Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S, 2023. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023. Available from: https://hpvcentre.net/statistics/reports/XWX.pdf. Accessed November 14, 2023.
-
3.
LaVigne AW , Triedman SA , Randall TC , Trimble EL , Viswanathan AN , 2017. Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery. Gynecol Oncol Rep 22: 16–20.
-
4.
Bruni L , Diaz M , Castellsagué M , Ferrer E , Bosch FX , de Sanjosé S , 2010. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202: 1789–1799.
-
5.
Ahmed S et al., 2023. Genotypic distribution of human papillomavirus and phylogenetic analysis of E6 and E7 gene of HR-HPV variants isolated from Pakistani population. Medicine (Baltimore) 102: e32651.
-
6.
Burchell AN , Winer RL , de Sanjosé S , Franco EL , 2006. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 24: S52–S61.
-
7.
Plummer M , Franceschi S , 2002. Strategies for HPV prevention. Virus Res 89: 285–293.
-
8.
Kitchener HC , Castle PE , Cox JT , 2006. Achievements and limitations of cervical cytology screening. Vaccine 24: S63–S70.
-
9.
Loya A , Serrano B , Rasheed F , Tous S , Hassan M , Clavero O , Raza M , De Sanjosé S , Bosch FX , Alemany L , 2016. Human papillomavirus genotype distribution in invasive cervical cancer in Pakistan. Cancers (Basel) 8: 72.
-
10.
Gele AA , Qureshi SA , Kour P , Kumar B , Diaz E , 2017. Barriers and facilitators to cervical cancer screening among Pakistani and Somali immigrant women in Oslo: A qualitative study. Int J Womens Health 6: 487–496.
-
11.
Ahmad M , Narayan E , Ahmed I , Bule MH , 2023. Inadequate cervical cancer testing facilities in Pakistan: A major public health concern. IJS Global Health 6: e0336.
-
12.
Riaz L , Manazir S , Jawed F , Ali SA , Riaz R , 2020. Knowledge, perception, and prevention practices related to human papillomavirus-based cervical cancer and its socioeconomic correlates among women in Karachi, Pakistan. Cureus 12: e7183.
-
13.
Portnoy A , Abbas K , Sweet S , Kim JJ , Jit M , 2021. Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: A comparative modelling study. BMJ Glob Health 6: e006940.
-
14.
Van Minh H , My NTT , Jit M , 2017. Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: A PRIME modeling study. BMC Health Serv Res 17: 1–7.
-
15.
Strategic Advisory Group of Experts (SAGE) on Immunization , 2022. Strategic Advisory Group of Experts (SAGE) Working Group on Potential Contribution of HPV Vaccines and Immunization towards Cervical Cancer Elimination: Background Document and Report to SAGE. Geneva, Switzerland: World Health Organization.
-
16.
World Health Organization , 2016. Guide to Introducing HPV Vaccine into National Immunization Programmes. Geneva, Switzerland: World Health Organization.
-
17.
Prem K et al., 2023. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: A comparative modelling analysis. BMC Med 21: 313.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1942 | 1359 | 241 |
| Full Text Views | 55 | 36 | 15 |
| PDF Downloads | 62 | 39 | 14 |